169 related articles for article (PubMed ID: 35676793)
1. Hospital costs associated with adverse events in people with diabetes in the UK.
Keng MJ; Leal J; Bowman L; Armitage J; Mihaylova B;
Diabetes Obes Metab; 2022 Nov; 24(11):2108-2117. PubMed ID: 35676793
[TBL] [Abstract][Full Text] [Related]
2. Decrements in health-related quality of life associated with adverse events in people with diabetes.
Keng MJ; Leal J; Bowman L; Armitage J; Mihaylova B;
Diabetes Obes Metab; 2022 Mar; 24(3):530-538. PubMed ID: 34866309
[TBL] [Abstract][Full Text] [Related]
3. Impact of New Cardiovascular Events on Quality of Life and Hospital Costs in People With Cardiovascular Disease in the United Kingdom and United States.
Lui JNM; Williams C; Keng MJ; Hopewell JC; Sammons E; Chen F; Gray A; Bowman L; Landray SMJ; Mihaylova B;
J Am Heart Assoc; 2023 Oct; 12(19):e030766. PubMed ID: 37750555
[TBL] [Abstract][Full Text] [Related]
4. Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (review of Technology Appraisal No. 90): a systematic review and economic analysis.
Greenhalgh J; Bagust A; Boland A; Martin Saborido C; Oyee J; Blundell M; Dundar Y; Dickson R; Proudlove C; Fisher M
Health Technol Assess; 2011 Sep; 15(31):1-178. PubMed ID: 21888837
[TBL] [Abstract][Full Text] [Related]
5. Risk of subsequent disabling or fatal stroke in patients with transient ischaemic attack or minor ischaemic stroke: an international, prospective cohort study.
Hobeanu C; Lavallée PC; Charles H; Labreuche J; Albers GW; Caplan LR; Donnan GA; Ferro JM; Hennerici MG; Molina CA; Rothwell PM; Steg PG; Touboul PJ; Uchiyama S; Vicaut E; Wong KSL; Amarenco P;
Lancet Neurol; 2022 Oct; 21(10):889-898. PubMed ID: 36115361
[TBL] [Abstract][Full Text] [Related]
6. A comprehensive analysis of the effects of rivaroxaban on stroke or transient ischaemic attack in patients with heart failure, coronary artery disease, and sinus rhythm: the COMMANDER HF trial.
Mehra MR; Vaduganathan M; Fu M; Ferreira JP; Anker SD; Cleland JGF; Lam CSP; van Veldhuisen DJ; Byra WM; Spiro TE; Deng H; Zannad F; Greenberg B
Eur Heart J; 2019 Nov; 40(44):3593-3602. PubMed ID: 31461239
[TBL] [Abstract][Full Text] [Related]
7. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.
Whitfield MD; Gillett M; Holmes M; Ogden E
Public Health; 2006 Dec; 120(12):1140-8. PubMed ID: 17084425
[TBL] [Abstract][Full Text] [Related]
8. Sex-specific temporal trends in the incidence and prevalence of cardiovascular disease in young adults: a population-based study using UK primary care data.
Okoth K; Crowe F; Marshall T; Thomas GN; Nirantharakumar K; Adderley NJ
Eur J Prev Cardiol; 2022 Aug; 29(10):1387-1395. PubMed ID: 35139185
[TBL] [Abstract][Full Text] [Related]
9. ESRD After Heart Failure, Myocardial Infarction, or Stroke in Type 2 Diabetic Patients With CKD.
Charytan DM; Solomon SD; Ivanovich P; Remuzzi G; Cooper ME; McGill JB; Parving HH; Parfrey P; Singh AK; Burdmann EA; Levey AS; de Zeeuw D; Eckardt KU; McMurray JJV; Claggett B; Lewis EF; Pfeffer MA
Am J Kidney Dis; 2017 Oct; 70(4):522-531. PubMed ID: 28599901
[TBL] [Abstract][Full Text] [Related]
10. Cerebral microbleeds and intracranial haemorrhage risk in patients anticoagulated for atrial fibrillation after acute ischaemic stroke or transient ischaemic attack (CROMIS-2): a multicentre observational cohort study.
Wilson D; Ambler G; Shakeshaft C; Brown MM; Charidimou A; Al-Shahi Salman R; Lip GYH; Cohen H; Banerjee G; Houlden H; White MJ; Yousry TA; Harkness K; Flossmann E; Smyth N; Shaw LJ; Warburton E; Muir KW; Jäger HR; Werring DJ;
Lancet Neurol; 2018 Jun; 17(6):539-547. PubMed ID: 29778365
[TBL] [Abstract][Full Text] [Related]
11. Annual direct medical costs associated with diabetes-related complications in the event year and in subsequent years in Hong Kong.
Jiao F; Wong CKH; Tang SCW; Fung CSC; Tan KCB; McGhee S; Gangwani R; Lam CLK
Diabet Med; 2017 Sep; 34(9):1276-1283. PubMed ID: 28636749
[TBL] [Abstract][Full Text] [Related]
12. The impact of diabetes-related complications on healthcare costs: new results from the UKPDS (UKPDS 84).
Alva ML; Gray A; Mihaylova B; Leal J; Holman RR
Diabet Med; 2015 Apr; 32(4):459-66. PubMed ID: 25439048
[TBL] [Abstract][Full Text] [Related]
13. Impact of atrial fibrillation on stroke-related healthcare costs.
Sussman M; Menzin J; Lin I; Kwong WJ; Munsell M; Friedman M; Selim M
J Am Heart Assoc; 2013 Nov; 2(6):e000479. PubMed ID: 24275631
[TBL] [Abstract][Full Text] [Related]
14. Prediction Models for Individual-Level Healthcare Costs Associated with Cardiovascular Events in the UK.
Zhou J; Wu R; Williams C; Emberson J; Reith C; Keech A; Robson J; Wilkinson K; Armitage J; Gray A; Simes J; Baigent C; Mihaylova B
Pharmacoeconomics; 2023 May; 41(5):547-559. PubMed ID: 36826687
[TBL] [Abstract][Full Text] [Related]
15. Predictive models for adverse clinical outcomes in Chinese patients with atrial fibrillation undergoing percutaneous coronary intervention with stenting.
Zheng JY; Cao Y; Li DT; Qiu YG; Zhao L; Xu ZM; Huang YX; Hong ZB; Li TC; Tang YD; Guo CJ; Ma ZM; Wu YQ; Chen Y
Acta Cardiol; 2022 Jun; 77(4):360-365. PubMed ID: 34353224
[TBL] [Abstract][Full Text] [Related]
16. All-cause and bleeding-related health care costs in warfarin-treated patients with atrial fibrillation.
Ghate SR; Biskupiak J; Ye X; Kwong WJ; Brixner DI
J Manag Care Pharm; 2011 Nov; 17(9):672-84. PubMed ID: 22050392
[TBL] [Abstract][Full Text] [Related]
17. Bleeding risk in patients prescribed dual antiplatelet therapy and triple therapy after coronary interventions: the ADAPTT retrospective population-based cohort studies.
Harris J; Pouwels KB; Johnson T; Sterne J; Pithara C; Mahadevan K; Reeves B; Benedetto U; Loke Y; Lasserson D; Doble B; Hopewell-Kelly N; Redwood S; Wordsworth S; Mumford A; Rogers C; Pufulete M
Health Technol Assess; 2023 May; 27(8):1-257. PubMed ID: 37435838
[TBL] [Abstract][Full Text] [Related]
18. Long term risks of stroke, myocardial infarction, and vascular death in "low risk" patients with a non-recent transient ischaemic attack.
Clark TG; Murphy MF; Rothwell PM
J Neurol Neurosurg Psychiatry; 2003 May; 74(5):577-80. PubMed ID: 12700296
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of Individuals With and Without Heart Failure Presenting With Acute Coronary Syndrome.
Clarkson SA; Heindl B; Cai A; Beasley M; Dillon C; Limdi N; Brown TM
Am J Cardiol; 2021 Jun; 148():1-7. PubMed ID: 33667441
[TBL] [Abstract][Full Text] [Related]
20. Derivation and validation of QStroke score for predicting risk of ischaemic stroke in primary care and comparison with other risk scores: a prospective open cohort study.
Hippisley-Cox J; Coupland C; Brindle P
BMJ; 2013 May; 346():f2573. PubMed ID: 23641033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
